Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

Université de Montréal

$56,900.00

Pulsatile displacement of the lamina cribrosa in the pathogenesis of glaucoma: development of a novel device and preliminary clinical testing

FY 2013-14

Summary
CONTEXT: The pathogenesis of open angle glaucoma is poorly understood. While intraocular pressure (IOP)is confirmed as a major factor, ocular blood flow and the elasticity of the sclera and lamina cribrosa may play arole. We propose a new theory uniting these three factors. We propose that the lamina cribrosa movesbackwards with each cardiac cycle, driven by the pulsatility of the choroid, while the retina moves in theopposite direction. These counter-directional movements could lead to stretch damage of axons that form theoptic nerve, which run from the retinal nerve fibre layer through the lamina cribrosa. This hypothesis is basedon our recent studies, which suggest that the biomechanical compliance of the lamina cribrosa differsdramatically between patients at risk of aggressive glaucoma and patients with stable glaucoma [Lesk et al.,Arch Ophthalmol, 124, 1568 (2006)], as well as on recent literature on the pulsatile movements of the retina.To test this hypothesis, we have developed a prototype of a novel non-invasive device based on LowCoherence Interferometry (LCI), which measures with high spatial (400 nm) and temporal resolution (0.01 sec)the movement of intraocular tissues, such as the retinal inner limiting layer and the lamina cribrosa [Singh et alExp Eye Res (April 14, 2010)]. This device has recently been successfully tested on human volunteers.OBJECTIVE: The objectives of this project are (A) to evaluate our theory on actual glaucoma patients atHôpital Maisonneuve-Rosemont (HMR) using the developed non-invasive device; (B) to improve theprototype device for better data acquisition and stability; (C) to develop image analysis protocols that permitthe efficient and reliable extraction of meaningful data; (D) to develop a complementary system with greaterlateral resolution on the platform of a commercially availible device.CONCLUSION: This project could lead to the first method to ascertain whether a patient with early glaucomais at high risk for rapid loss of vision, and thus requires early aggressive therapy.Ultimately, improvedunderstanding on the pathophysiology of glaucoma could lead to new therapeutic modalities.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
398121-2011
Name nom
Lesk, Mark
Department département
Médecine
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2011
Award amount
56900
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3110
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Optics (see also photon devices2505)
Research subject fr
Optique (voir aussi dispositifs photoniques, 2505)
Partie
3
Nb partie
3
Application title
Pulsatile displacement of the lamina cribrosa in the pathogenesis of glaucoma: development of a novel device and preliminary clinical testing
Keyword
NSERC
Application summary
CONTEXT: The pathogenesis of open angle glaucoma is poorly understood. While intraocular pressure (IOP)is confirmed as a major factor, ocular blood flow and the elasticity of the sclera and lamina cribrosa may play arole. We propose a new theory uniting these three factors. We propose that the lamina cribrosa movesbackwards with each cardiac cycle, driven by the pulsatility of the choroid, while the retina moves in theopposite direction. These counter-directional movements could lead to stretch damage of axons that form theoptic nerve, which run from the retinal nerve fibre layer through the lamina cribrosa. This hypothesis is basedon our recent studies, which suggest that the biomechanical compliance of the lamina cribrosa differsdramatically between patients at risk of aggressive glaucoma and patients with stable glaucoma [Lesk et al.,Arch Ophthalmol, 124, 1568 (2006)], as well as on recent literature on the pulsatile movements of the retina.To test this hypothesis, we have developed a prototype of a novel non-invasive device based on LowCoherence Interferometry (LCI), which measures with high spatial (400 nm) and temporal resolution (0.01 sec)the movement of intraocular tissues, such as the retinal inner limiting layer and the lamina cribrosa [Singh et alExp Eye Res (April 14, 2010)]. This device has recently been successfully tested on human volunteers.OBJECTIVE: The objectives of this project are (A) to evaluate our theory on actual glaucoma patients atHôpital Maisonneuve-Rosemont (HMR) using the developed non-invasive device; (B) to improve theprototype device for better data acquisition and stability; (C) to develop image analysis protocols that permitthe efficient and reliable extraction of meaningful data; (D) to develop a complementary system with greaterlateral resolution on the platform of a commercially availible device.CONCLUSION: This project could lead to the first method to ascertain whether a patient with early glaucomais at high risk for rapid loss of vision, and thus requires early aggressive therapy.Ultimately, improvedunderstanding on the pathophysiology of glaucoma could lead to new therapeutic modalities.